Skip Nav Destination
Issues
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Advances in Brief
Alterations of Gene Expression during Colorectal Carcinogenesis Revealed by cDNA Microarrays after Laser-Capture Microdissection of Tumor Tissues and Normal Epithelia1
Osamu Kitahara; Yoichi Furukawa; Toshihiro Tanaka; Chikashi Kihara; Kenji Ono; Renpei Yanagawa; Marcelo E. Nita; Toshihisa Takagi; Yusuke Nakamura; Tatsuhiko Tsunoda
The Histone Deacetylase Inhibitor, CBHA, Inhibits Growth of Human Neuroblastoma Xenografts in Vivo, Alone and Synergistically with All-Trans Retinoic Acid1
Dennis C. Coffey; Martha C. Kutko; Richard D. Glick; Lisa M. Butler; Glenn Heller; Richard A. Rifkind; Paul A. Marks; Victoria M. Richon; Michael P. La Quaglia
Biochemistry and Biophysics
Tissue Inhibitor of Metalloproteinases-4 Inhibits But Does Not Support the Activation of Gelatinase A via Efficient Inhibition of Membrane Type 1-Matrix Metalloproteinase1
Heather F. Bigg; Charlotte J. Morrison; Georgina S. Butler; Marie A. Bogoyevitch; Zhiping Wang; Paul D. Soloway; Christopher M. Overall
Carcinogenesis
Endocrinology
Epidemiology and Prevention
Experimental Therapeutics
Modulation of Both Endogenous Folates and Thymidine Enhance the Therapeutic Efficacy of Thymidylate Synthase Inhibitors1
Clasina L. van der Wilt; Harold H. J. Backus; Kees Smid; Lizzy Comijn; Gijsbert Veerman; Dorine Wouters; Daphne A. Voorn; David G. Priest; Marlene A. Bunni; Fraser Mitchell; Ann L. Jackman; Gerrit Jansen; Godefridus J. Peters
Immunology
Cyclophosphamide, Doxorubicin, and Paclitaxel Enhance the Antitumor Immune Response of Granulocyte/Macrophage-Colony Stimulating Factor-secreting Whole-Cell Vaccines in HER-2/neu Tolerized Mice1
Jean-Pascal H. Machiels; R. Todd Reilly; Leisha A. Emens; Anne M. Ercolini; Rachel Y. Lei; Diane Weintraub; Francesca I. Okoye; Elizabeth M. Jaffee
Immunoscintigraphy with Positron Emission Tomography: Gallium-68 Chelate Imaging of Breast Cancer Pretargeted with Bispecific Anti-MUC1/Anti-Ga Chelate Antibodies
Jochen Schuhmacher; Sepp Kaul; Gabor Klivényi; Hans Junkermann; Achim Magener; Marcus Henze; Josef Doll; Uwe Haberkorn; Folker Amelung; Gunther Bastert
High Frequency of Cytolytic T Lymphocytes Directed against a Tumor-specific Mutated Antigen Detectable with HLA Tetramers in the Blood of a Lung Carcinoma Patient with Long Survival1
Vaios Karanikas; Didier Colau; Jean-François Baurain; Rita Chiari; Joëlle Thonnard; Ilse Gutierrez-Roelens; Céline Goffinet; Emile Van Schaftingen; Patrick Weynants; Thierry Boon; Pierre G. Coulie
Molecular and Biology and Genetics
Tumor Necrosis Factor α Polymorphism Associated with Increased Susceptibility to Development of Adult T-Cell Leukemia/Lymphoma in Human T-lymphotropic Virus Type 1 Carriers1
Kunihiro Tsukasaki; Carl W. Miller; Tetsuya Kubota; Seisho Takeuchi; Takeshi Fujimoto; Shuichi Ikeda; Masao Tomonaga; H. Philip Koeffler
Tumor Biology
Virology
Human Papillomavirus Type 16 E6 and E7 Cooperate to Increase Epidermal Growth Factor Receptor (EGFR) mRNA Levels, Overcoming Mechanisms by which Excessive EGFR Signaling Shortens the Life Span of Normal Human Keratinocytes1, 2
Gregory S. Akerman; William H. Tolleson; Kim L. Brown; Li Li Zyzak; Elena Mourateva; Timur S. W. Engin; Anamaria Basaraba; Ann L. Coker; Kim E. Creek; Lucia Pirisi
Meeting Report
Obituary
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.